Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 51 to 75 of 2013

TitleReference numberPublishedLast updated
Durvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapyTA1099
Mirabegron for treating neurogenic detrusor overactivity in people 3 to 17 years (terminated appraisal)TA1100
HIV testing: increasing uptake among people who may have undiagnosed HIVNG60
Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitableTA1098
Atopic eczema in under 12s: diagnosis and managementCG57
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessmentHTG718
Enfortumab vedotin with pembrolizumab for untreated unresectable or metastatic urothelial cancer when platinum-based chemotherapy is suitableTA1097
Chronic heart failure in adults: diagnosis and managementNG106
Benralizumab for treating relapsing or refractory eosinophilic granulomatosis with polyangiitisTA1096
Bipolar disorder: assessment and managementCG185
Suspected acute respiratory infection in over 16s: assessment at first presentation and initial managementNG237
Pneumonia: diagnosis and managementNG250
Tirzepatide for managing overweight and obesityTA1026
Tirzepatide for treating type 2 diabetesTA924
Idebenone for treating visual impairment in Leber's hereditary optic neuropathy in people 12 years and overTA1093
Guselkumab for treating moderately to severely active ulcerative colitisTA1094
Guselkumab for previously treated moderately to severely active Crohn's diseaseTA1095
Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancerTA1092
Compression products for treating venous leg ulcers: late-stage assessmentHTG758
Bed frames for adults in acute medical or surgical hospital wards: late-stage assessmentHTG759
Transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis: late-stage assessmentHTG757
Tarlatamab for extensive-stage small-cell lung cancer after 2 or more treatmentsTA1091
Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinomaTA1090
Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and overTA1088
Sacituzumab govitecan for treating hormone receptor-positive HER2-negative metastatic breast cancer after 2 or more treatments (terminated appraisal)TA1089

Results per page

  1. 10
  2. 25
  3. 50
  4. All